Published in Eur Arch Psychiatry Clin Neurosci on March 16, 2011
Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance. Neuropsychopharmacology (2013) 0.96
Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate. Eur Arch Psychiatry Clin Neurosci (2012) 0.87
Marine Ο-3 polyunsaturated fatty acids induce sex-specific changes in reinforcer-controlled behaviour and neurotransmitter metabolism in a spontaneously hypertensive rat model of ADHD. Behav Brain Funct (2012) 0.86
The role of a mineralocorticoid receptor gene functional polymorphism in the symptom dimensions of persistent ADHD. Eur Arch Psychiatry Clin Neurosci (2012) 0.83
Neural correlates of inhibitory control and functional genetic variation in the dopamine D4 receptor gene. Neuropsychologia (2014) 0.81
Speech-Sound Disorders and Attention-Deficit/Hyperactivity Disorder Symptoms. Top Lang Disord (2012) 0.81
A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism. Behav Brain Funct (2015) 0.78
Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome. J Neurodev Disord (2014) 0.77
Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults. Eur Arch Psychiatry Clin Neurosci (2014) 0.76
Hardy-Weinberg equilibrium analysis of the 48 bp VNTR in the III exon of the DRD4 gene in a sample of parents of ADHD cases. Appl Clin Genet (2015) 0.76
The handedness-associated PCSK6 locus spans an intronic promoter regulating novel transcripts. Hum Mol Genet (2016) 0.75
Testing for the mediating role of endophenotypes using molecular genetic data in a twin study of ADHD traits. Am J Med Genet B Neuropsychiatr Genet (2016) 0.75
Satiety and the Self-Regulation of Food Take in Children: a Potential Role for Gene-Environment Interplay. Curr Obes Rep (2016) 0.75
PI3K signaling in the locus coeruleus: a new molecular pathway for ADHD research. EMBO Mol Med (2015) 0.75
Mood disorders in the light of genes, comorbidity and contemporary treatment. Eur Arch Psychiatry Clin Neurosci (2011) 0.75
Associations between catecholaminergic, GABAergic, and serotonergic genes and self-reported attentional function in oncology patients and their family caregivers. Eur J Oncol Nurs (2014) 0.75
Interaction effects of GIT1 and DRD4 gene variants on continuous performance test variables in patients with ADHD. Brain Behav (2017) 0.75
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry (2003) 21.70
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry (2007) 14.02
Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull (1997) 13.33
Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85
Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 7.94
Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry (2005) 7.90
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics (1996) 6.83
Attention-deficit hyperactivity disorder. Lancet (2005) 5.75
Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci (2006) 5.70
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci (2002) 5.50
A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet (1998) 3.59
Candidate gene studies of ADHD: a meta-analytic review. Hum Genet (2009) 3.56
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem (1995) 3.08
Maternal smoking habits and cognitive development of children at age 4 years in a population-based birth cohort. Int J Epidemiol (2007) 2.55
The endophenotype concept in psychiatric genetics. Psychol Med (2006) 2.49
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci (2002) 2.46
Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology (2000) 2.28
Modeling attention-deficit/hyperactivity disorder: a critical appraisal of the cognitive-energetic model. Biol Psychiatry (2004) 2.20
Functional gene group analysis reveals a role of synaptic heterotrimeric G proteins in cognitive ability. Am J Hum Genet (2010) 2.02
Comorbidity of reading disability and attention-deficit/hyperactivity disorder: differences by gender and subtype. J Learn Disabil (2004) 1.92
Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci (1998) 1.88
Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects. Psychol Med (2007) 1.85
A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet (2001) 1.80
Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J Neurosci (1994) 1.71
A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res (2000) 1.67
Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol (2003) 1.59
Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci U S A (2000) 1.53
The genetics of attention deficit hyperactivity disorder. Clin Psychol Rev (2006) 1.53
Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Neuropsychologia (2005) 1.49
Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Child Psychol Psychiatry (2005) 1.47
Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet (2005) 1.47
Executive dysfunction and delay aversion in attention deficit hyperactivity disorder: nosologic and diagnostic implications. Child Adolesc Psychiatr Clin N Am (2008) 1.47
Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J Comp Neurol (1989) 1.44
Testing for neuropsychological endophenotypes in siblings discordant for attention-deficit/hyperactivity disorder. Biol Psychiatry (2007) 1.41
Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
Support for an independent familial segregation of executive and intelligence endophenotypes in ADHD families. Psychol Med (2008) 1.27
Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psychiatry (2004) 1.26
Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav (2006) 1.24
Neuropsychological endophenotype approach to genome-wide linkage analysis identifies susceptibility loci for ADHD on 2q21.1 and 13q12.11. Am J Hum Genet (2008) 1.23
Cellular and subcellular localization of the dopamine transporter in rat cortex. Adv Pharmacol (1998) 1.21
Deficient response inhibition as a cognitive endophenotype of ADHD. J Am Acad Child Adolesc Psychiatry (2003) 1.20
Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.20
Speed, variability, and timing of motor output in ADHD: which measures are useful for endophenotypic research? Behav Genet (2007) 1.19
The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur Neuropsychopharmacol (2005) 1.15
Executive functions as endophenotypes in ADHD: evidence from the Cambridge Neuropsychological Test Battery (CANTAB). J Child Psychol Psychiatry (2010) 1.13
SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families. Am J Med Genet B Neuropsychiatr Genet (2008) 1.12
Delay Aversion in Attention Deficit/Hyperactivity Disorder: an empirical investigation of the broader phenotype. Neuropsychologia (2008) 1.10
An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuropsychiatr Genet (2006) 1.09
The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci Biobehav Rev (2003) 1.08
Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. J Psychiatry Neurosci (2009) 1.07
Comorbid problems in ADHD: degree of association, shared endophenotypes, and formation of distinct subtypes. Implications for a future DSM. J Abnorm Child Psychol (2009) 1.07
Functional effects of the DAT1 polymorphism on EEG measures in ADHD. J Am Acad Child Adolesc Psychiatry (2003) 1.07
Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci (2007) 1.06
Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet (1999) 1.06
Multivariate genomewide linkage scan of neurocognitive traits and ADHD symptoms: suggestive linkage to 3q13. Am J Med Genet B Neuropsychiatr Genet (2008) 1.03
Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: evidence from 2 birth cohorts. Arch Gen Psychiatry (2006) 1.02
The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry (2002) 1.02
Effects of maternal and paternal smoking on attentional control in children with and without ADHD. Eur Child Adolesc Psychiatry (2009) 1.02
The cognitive genetics of attention deficit hyperactivity disorder (ADHD): sustained attention as a candidate phenotype. Cortex (2006) 1.01
DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): effects of associated alleles at the VNTR and -521 SNP. Am J Med Genet B Neuropsychiatr Genet (2005) 0.98
Time reproduction in children with ADHD and their nonaffected siblings. J Am Acad Child Adolesc Psychiatry (2007) 0.98
The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD. Am J Med Genet B Neuropsychiatr Genet (2008) 0.98
Deficient inhibition as a marker for familial ADHD. Am J Psychiatry (2001) 0.97
Cognitive functioning in affected sibling pairs with ADHD: familial clustering and dopamine genes. J Child Psychol Psychiatry (2008) 0.96
Validation and extension of the endophenotype model in ADHD patterns of inheritance in a family study of inhibitory control. Am J Psychiatry (2009) 0.96
The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD. Exp Brain Res (2005) 0.95
A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD. Am J Med Genet B Neuropsychiatr Genet (2008) 0.94
The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD. Cogn Affect Behav Neurosci (2006) 0.94
An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD. Am J Med Genet B Neuropsychiatr Genet (2008) 0.94
Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications. Eur Arch Psychiatry Clin Neurosci (2008) 0.93
Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Mol Psychiatry (2004) 0.93
The dopamine D4 receptor gene and moderation of the association between externalizing behavior and IQ. Arch Gen Psychiatry (2006) 0.92
Association between DRD4 gene and performance of children with ADHD in a test of sustained attention. Biol Psychiatry (2006) 0.91
Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals. Mol Psychiatry (2008) 0.90
II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. J Pharmacol Exp Ther (1997) 0.89
Absence of the 7-repeat variant of the DRD4 VNTR is associated with drifting sustained attention in children with ADHD but not in controls. Am J Med Genet B Neuropsychiatr Genet (2008) 0.89
Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA). Am J Med Genet B Neuropsychiatr Genet (2004) 0.87
Possible association of the alpha-2A-adrenergic receptor gene with response time variability in attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 0.87
Association study of the brain-derived neurotropic factor (BDNF) gene in attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2007) 0.86
Differential association between MAOA, ADHD and neuropsychological functioning in boys and girls. Am J Med Genet B Neuropsychiatr Genet (2008) 0.86
Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD. BMC Med Genet (2004) 0.85
Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci (2005) 0.85
No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample. Neuropsychobiology (2008) 0.84
No evidence of association between Catechol-O-Methyltransferase (COMT) Val158Met genotype and performance on neuropsychological tasks in children with ADHD: a case-control study. BMC Psychiatry (2004) 0.84
The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample. J Psychiatr Res (2005) 0.84
Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD. BMC Psychiatry (2008) 0.82
Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD. Neuropsychopharmacology (2007) 0.82
Relationship between endophenotype and phenotype in ADHD. Behav Brain Funct (2008) 0.82
Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 0.81
Neuropsychological measures probably facilitate heritability research of ADHD. Arch Clin Neuropsychol (2008) 0.81
Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2009) 0.81
Familiality and molecular genetics of attention networks in ADHD. Am J Med Genet B Neuropsychiatr Genet (2010) 0.81
Dopamine transporter genotype influences the attention deficit in Korean boys with ADHD. Yonsei Med J (2003) 0.81
Impaired temporal resolution of visual attention and dopamine beta hydroxylase genotype in attention-deficit/hyperactivity disorder. Biol Psychiatry (2006) 0.80
Association between tryptophan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants. Am J Med Genet B Neuropsychiatr Genet (2008) 0.80
No association between dopaminergic polymorphisms and intelligence variability in attention-deficit/hyperactivity disorder. Mol Psychiatry (2006) 0.79
The gene for synapsin III and attention-deficit hyperactivity disorder. Psychiatr Genet (2007) 0.79
Gene-gene interaction between COMT and MAOA potentially predicts the intelligence of attention-deficit hyperactivity disorder boys in China. Behav Genet (2009) 0.78
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet (2009) 2.43
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet (2011) 1.94
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia. Br J Psychiatry (2012) 1.70
Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet (2008) 1.66
Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder. Can J Psychiatry (2013) 1.61
NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am J Med Genet B Neuropsychiatr Genet (2005) 1.60
Intranasal oxytocin impedes the ability to ignore task-irrelevant facial expressions of sadness in students with depressive symptoms. Psychoneuroendocrinology (2012) 1.42
Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry (2002) 1.37
Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 1.25
Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings. J Psychiatry Neurosci (2005) 1.18
First-episode psychosis, early intervention, and outcome: what have we learned? Can J Psychiatry (2005) 1.18
Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia. Genomics (2003) 1.17
Dopamine genes and attention-deficit hyperactivity disorder: a review. J Psychiatry Neurosci (2003) 1.17
Determinants of help-seeking and system related components of delay in the treatment of first-episode psychosis. Schizophr Res (2007) 1.14
Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res (2004) 1.13
Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci (2008) 1.10
Is the inattentive subtype of ADHD different from the combined/hyperactive subtype? J Atten Disord (2009) 1.09
Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. J Psychiatry Neurosci (2009) 1.07
Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial. J Psychiatry Neurosci (2006) 1.07
The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. Int J Eat Disord (2005) 1.07
Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? Schizophr Res (2008) 1.06
Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study. Psychoneuroendocrinology (2012) 1.05
Serotonin-system polymorphisms (5-HTTLPR and -1438G/A) and responses of patients with bulimic syndromes to multimodal treatments. J Clin Psychiatry (2008) 1.05
Mutation screening of FOXP2 in individuals diagnosed with autistic disorder. Am J Med Genet A (2003) 1.03
Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD. BMC Psychiatry (2011) 1.02
The acute effects of intranasal oxytocin on automatic and effortful attentional shifting to emotional faces. Psychophysiology (2011) 1.02
Education modulates cortisol reactivity to the Trier Social Stress Test in middle-aged adults. Psychoneuroendocrinology (2007) 1.01
The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis. J Clin Psychiatry (2014) 0.99
A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. J Clin Psychopharmacol (2010) 0.99
Effectiveness of a therapeutic summer camp for children with ADHD: Phase I Clinical Intervention Trial. J Atten Disord (2011) 0.97
Selective abnormal modulation of hippocampal activity during memory formation in first-episode psychosis. Arch Gen Psychiatry (2007) 0.97
Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophr Res (2010) 0.96
Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophr Res (2011) 0.96
Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study. J Psychiatr Res (2010) 0.96
Cognitive insight and verbal memory in first episode of psychosis. Eur Psychiatry (2008) 0.94
Development and persistence of posttraumatic stress disorder and the 5-HTTLPR polymorphism. J Trauma Stress (2009) 0.93
Association of trait-defined, eating-disorder sub-phenotypes with (biallelic and triallelic) 5HTTLPR variations. J Psychiatr Res (2009) 0.93
Publication bias: what are the challenges and can they be overcome? J Psychiatry Neurosci (2012) 0.91
Maternal smoking during pregnancy and ADHD: a comprehensive clinical and neurocognitive characterization. Nicotine Tob Res (2012) 0.91
Association between 7q31 markers and Tourette syndrome. Am J Med Genet A (2004) 0.90
Performance on the continuous performance test in children with ADHD is associated with sleep efficiency. Sleep (2007) 0.90
Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study. Am J Med Genet B Neuropsychiatr Genet (2003) 0.90
Serotonin transporter, stressful life events, and depression severity. Am J Psychiatry (2007) 0.90
Early intervention for psychosis: a Canadian perspective. J Nerv Ment Dis (2015) 0.90
Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa. Am J Med Genet B Neuropsychiatr Genet (2005) 0.89
Understanding putative risk factors for schizophrenia: retrospective and prospective studies. J Psychiatry Neurosci (2005) 0.88
The 5HTTLPR polymorphism, prior maltreatment and dramatic-erratic personality manifestations in women with bulimic syndromes. J Psychiatry Neurosci (2007) 0.88
Intrafamilial correspondences on platelet [3H-]paroxetine-binding indices in bulimic probands and their unaffected first-degree relatives. Neuropsychopharmacology (2006) 0.88
LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy. J Child Psychol Psychiatry (2012) 0.87
Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly. J Med Genet (2013) 0.87
The parahippocampal gyrus as a neural marker of early remission in first-episode psychosis: a voxel-based morphometry study. Clin Schizophr Relat Psychoses (2011) 0.87
Maternal Stress during Pregnancy, ADHD Symptomatology in Children and Genotype: Gene-Environment Interaction. J Can Acad Child Adolesc Psychiatry (2012) 0.87
Differential effects of adrenergic and corticosteroid hormonal systems on human short- and long-term declarative memory for emotionally arousing material. Behav Neurosci (2004) 0.87
The structural neural substrates of persistent negative symptoms in first-episode of non-affective psychosis: a voxel-based morphometry study. Front Psychiatry (2012) 0.87
Identifying persistent negative symptoms in first episode psychosis. BMC Psychiatry (2012) 0.87
Cognitive markers of short-term clinical outcome in first-episode psychosis. Br J Psychiatry (2008) 0.87
Childhood trauma and dissociation in first-episode psychosis, chronic schizophrenia and community controls. Psychiatry Res (2013) 0.86
Family-based association study of ADHD and genes increasing the risk for smoking behaviours. Arch Dis Child (2012) 0.86
Intranasal oxytocin and salivary cortisol concentrations during social rejection in university students. Stress (2011) 0.86
Case manager- and patient-rated alliance as a predictor of medication adherence in first-episode psychosis. J Clin Psychopharmacol (2012) 0.86
Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo. J Am Acad Child Adolesc Psychiatry (2004) 0.86
Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders. Can J Psychiatry (2010) 0.86
Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2009) 0.85
Relevance of the 5-HTTLPR polymorphism and childhood abuse to increased psychiatric comorbidity in women with bulimia-spectrum disorders. J Clin Psychiatry (2008) 0.85
Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD. BMC Med Genet (2004) 0.85
No association between the DRD3 Ser9Gly polymorphism and schizophrenia. Schizophr Res (2007) 0.85
Disrupted integrity of the fornix in first-episode schizophrenia. Schizophr Res (2010) 0.85
Methylation of the dopamine D2 receptor (DRD2) gene promoter in women with a bulimia-spectrum disorder: associations with borderline personality disorder and exposure to childhood abuse. J Psychiatr Res (2013) 0.84
Schizotypy, attention deficit hyperactivity disorder, and dopamine genes. Psychiatry Clin Neurosci (2006) 0.84
Association between schizophrenia and genetic variation in DCC: a case-control study. Schizophr Res (2012) 0.84
Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis. Can J Psychiatry (2009) 0.84
COMT Val108/158Met gene variant, birth weight, and conduct disorder in children with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 0.84
Physical activity experiences of boys with and without ADHD. Adapt Phys Activ Q (2009) 0.84
Cortical thickness is associated with poor insight in first-episode psychosis. J Psychiatr Res (2010) 0.84
The effects of glucocorticoids on the inhibition of emotional information: A dose-response study. Biol Psychol (2010) 0.83
Sensitivity of scales to evaluate change in symptomatology with psychostimulants in different ADHD subtypes. J Can Acad Child Adolesc Psychiatry (2013) 0.83
Fundamental movement skills and children with attention-deficit hyperactivity disorder: peer comparisons and stimulant effects. J Abnorm Child Psychol (2007) 0.83
Coping style moderates the effect of intranasal oxytocin on the mood response to interpersonal stress. Exp Clin Psychopharmacol (2011) 0.83
The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD. BMC Psychiatry (2010) 0.83
Sensitivity of tests to assess improvement in ADHD symptomatology. Can Child Adolesc Psychiatr Rev (2004) 0.83
Declarative memory after stress in humans: differential involvement of the beta-adrenergic and corticosteroid systems. J Clin Endocrinol Metab (2004) 0.83
Diagnostic stability of first-episode psychotic disorders and persistence of comorbid psychiatric disorders over 1 year. Can J Psychiatry (2013) 0.83
Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families. J Am Acad Child Adolesc Psychiatry (2006) 0.82
Is there an association between neurocognitive performance and medication adherence in first episode psychosis? Early Interv Psychiatry (2010) 0.82
Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy. PLoS One (2012) 0.82
Acute and long-term associations between ApoE genetic polymorphism, cortisol levels, and declarative memory performance in older adults. Psychoneuroendocrinology (2008) 0.82
Validation of the English and French versions of the Community Assessment of Psychic Experiences (CAPE) with a Montreal community sample. Schizophr Res (2007) 0.82
Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD. BMC Psychiatry (2008) 0.82
Body weight and ADHD: examining the role of self-regulation. PLoS One (2013) 0.82
CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophrenia. Brain Res Mol Brain Res (2005) 0.82
Sleep and COMT polymorphism in ADHD children: preliminary actigraphic data. J Am Acad Child Adolesc Psychiatry (2006) 0.82
Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders. Schizophr Res (2005) 0.82
Association between obesity-related gene FTO and ADHD. Obesity (Silver Spring) (2013) 0.82